Ultromics
@ultromics.com
Transforming the detection of heart failure with AI | www.ultromics.com
EchoGo® Heart Failure was developed with Mayo Clinic.
Patricia A. Pellikka, MD shares her views on the impact of our AI platform in detecting heart failure patients. Learn more about how EchoGo® Heart Failure supports #HeartFailure detection: www.ultromics.com/products/ech... #CardioSky #MedSky
Patricia A. Pellikka, MD shares her views on the impact of our AI platform in detecting heart failure patients. Learn more about how EchoGo® Heart Failure supports #HeartFailure detection: www.ultromics.com/products/ech... #CardioSky #MedSky
January 31, 2025 at 6:05 PM
EchoGo® Heart Failure was developed with Mayo Clinic.
Patricia A. Pellikka, MD shares her views on the impact of our AI platform in detecting heart failure patients. Learn more about how EchoGo® Heart Failure supports #HeartFailure detection: www.ultromics.com/products/ech... #CardioSky #MedSky
Patricia A. Pellikka, MD shares her views on the impact of our AI platform in detecting heart failure patients. Learn more about how EchoGo® Heart Failure supports #HeartFailure detection: www.ultromics.com/products/ech... #CardioSky #MedSky
EchoGo® Amyloidosis is the first AI screening tool to help detect Cardiac #Amyloidosis using #EchoFirst. Seamlessly integrating into clinical workflows, it supports timely identification and intervention. 👉 www.ultromics.com/products/ech... #MedSky #CardioSky
January 28, 2025 at 4:08 PM
EchoGo® Amyloidosis is the first AI screening tool to help detect Cardiac #Amyloidosis using #EchoFirst. Seamlessly integrating into clinical workflows, it supports timely identification and intervention. 👉 www.ultromics.com/products/ech... #MedSky #CardioSky
EchoGo® Heart Failure is eligible for reimbursement in both inpatient & outpatient settings & includes
#HFpEF & Cardiac Amyloidosis detection to aid care in #HeartFailure.
💰 Inpatient: NTAP XXE2X19 – Up to $1,023.75
💰 Outpatient: CPT 0932T – $299.91
👉https://www.ultromics.com/about/reimbursement
#HFpEF & Cardiac Amyloidosis detection to aid care in #HeartFailure.
💰 Inpatient: NTAP XXE2X19 – Up to $1,023.75
💰 Outpatient: CPT 0932T – $299.91
👉https://www.ultromics.com/about/reimbursement
January 8, 2025 at 4:12 PM
EchoGo® Heart Failure is eligible for reimbursement in both inpatient & outpatient settings & includes
#HFpEF & Cardiac Amyloidosis detection to aid care in #HeartFailure.
💰 Inpatient: NTAP XXE2X19 – Up to $1,023.75
💰 Outpatient: CPT 0932T – $299.91
👉https://www.ultromics.com/about/reimbursement
#HFpEF & Cardiac Amyloidosis detection to aid care in #HeartFailure.
💰 Inpatient: NTAP XXE2X19 – Up to $1,023.75
💰 Outpatient: CPT 0932T – $299.91
👉https://www.ultromics.com/about/reimbursement